Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by rejajon Mar 28, 2024 11:33am
121 Views
Post# 35958082

One conference call - much to discuss

One conference call - much to discussThe comments related to Labs Q4 and Full Year results have been very interesting.  The full spectrum of reactions and emotions are all there as would be expected given the details provided in the conference call.
 
It’s undeniable there has been an improvement in Gross Margin and Revenue and a reduction in Operating Expenses.   These important levers of business are all moving in the right direction.  The company is still not quite making money – but there are headwinds to this business in the form of taxes and other regulatory requirements that other businesses don’t’ have to deal with.  The acquisition of Vivo could have turned out quite differently if management wasn’t focused on the right things so that is a positive.
 
In my opinion profitability for this company will happen at some point either with or without any Excise Tax changes so I’m not too worried about that, although sooner would be better as $18m in cash is nice, but as a business you tend to burn through that if not making money.  It’s quite admirable that they are so close to profitability given the business headwinds.  As pointed out in some of the comments, just look at the financial position of the some of the other cannabis companies like Canopy Growth.
 
Sales increased by 50%.  That seems eye popping at first glance but that was generally accepted as being the case.  After all they acquired Vivo and by extension their associated sales.  Same for the reduction in OPEX.  If you can't find synergies in an acquired business - you're not doing the job right.
 
There is understandable frustration in discerning the segments of business – Canada vs Germany vs Australia vs Brazil.  From the transcript we do know that international sales are 30% of total sales, which makes Canada worth 70%.  After that I haven’t had the patience to work out the portions for Australia and Germany, while Brazil is a work in progress.  I’m sure with some relational digging the numbers could be worked out.  I might just try e-mailing the company to see if they are willing to provide that detail rather than poking around in a muck of numbers.
 
All in all the general direction of the basic levers of business are moving in the right direction.  Q1 results will probably come around May and those will tell us even more.  At this price potential returns are quite lucrative, and a takeover is always possible. 
 
Everything indicates that a bit of patience is all that is required  for this one (as frustrating as that may be).
<< Previous
Bullboard Posts
Next >>